(Q37575649)

21 August 2017

1 reference

title

ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs (English)

1 reference

21 August 2017

1 reference

1 reference

Sarah Vautier

1

1 reference

PubMed ID

19663741

21 August 2017

Christine Fernandez

series ordinal

2

1 reference

PubMed ID

19663741

21 August 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

Expert Opinion on Drug Metabolism & Toxicology

21 August 2017

1 reference

21 August 2017

5

1 reference

21 August 2017

11

1 reference

21 August 2017

1349-1358

1 reference

Drug resistance in hematologic malignancies

21 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Expression and function of multidrug resistance transporters at the blood-brain barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Altered P-glycoprotein expression in AIDS patients with HIV encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

beta-Amyloid efflux mediated by p-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Diagnosis and treatment of Parkinson disease: molecules to medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Pesticides and risk of Parkinson disease: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Parkinson's disease: a case-control study of occupational and environmental risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Environmental risk factors and Parkinson's disease: a case-control study in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Toxin-induced models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Effect of organophosphate pesticide diazinon on expression and activity of intestinal P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Differential effects of the organochlorine pesticide DDT and its metabolite p,p'-DDE on p-glycoprotein activity and expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Toxicity of Annonaceae for dopaminergic neurons: potential role in atypical parkinsonism in Guadeloupe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Essential structural factors of acetogenins, potent inhibitors of mitochondrial complex I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

(-)-Roemerine, an aporphine alkaloid from Annona senegalensis that reverses the multidrug-resistance phenotype with cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Expression and function of efflux drug transporters in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Association of a polymorphism in the ABCB1 gene with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Effect of MDR1 haplotype on risk of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

MDR1 variants and risk of Parkinson disease. Association with pesticide exposure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Neuroinflammatory processes in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Breakdown of the blood-brain barrier in murine cerebral malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Regulation of multidrug resistance by pro-inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Cytokine regulation of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Influence of tumor necrosis factor-alpha on the expression and function of P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Gene transfer of human TNF alpha into glioblastoma cells permits modulation of mdr1 expression and potentiation of chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Shiga-like toxin II modifies brain distribution of a P-glycoprotein substrate, doxorubicin, and P-glycoprotein expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Expression of multi-drug resistance 1 mRNA in human and rodent tissues: reduced levels in Parkinson patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Sleep attacks in patients taking dopamine agonists: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Bromocriptine transcriptionally activates the multidrug resistance gene (pgp2/mdr1b) by a novel pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Bromocriptine modulates P-glycoprotein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Bromocriptine reverses P-glycoprotein-mediated multidrug resistance in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Interactions between antiparkinsonian drugs and ABCB1/P-glycoprotein at the blood-brain barrier in a rat brain endothelial cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Interactions between the dopamine agonist, bromocriptine and the efflux protein, P-glycoprotein at the blood-brain barrier in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Evidence for the involvement of P-glycoprotein on the extrusion of taken up L-DOPA in cyclosporine A treated LLC-PK1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

The anti-Parkinson drug budipine is exported actively out of the brain by P-glycoprotein in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

The dynamics of blood-brain barrier breakdown in an experimental model of glial cell degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Preprohypocretin polymorphisms in Parkinson disease patients reporting "sleep attacks".

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

The impact of efflux transporters in the brain on the development of drugs for CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Breast cancer resistance protein in pharmacokinetics and drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Analysis of MDR1 haplotypes in Parkinson's disease in a white population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Genetic analysis of coding SNPs in blood-brain barrier transporter MDR1 in European Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

Digoxin pharmacokinetics and MDR1 genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

P-glycoprotein induction: an antidotal pathway for paraquat-induced lung toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903193079

10.1517/17425250903193079

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19663741